About Metatron Innovative Technologies International Association

The International Association of Innovative Technologies "Metatron" was created in 2022.

The official international name is Metatron Innovative Technologies International Association (abbreviated as MITIA).

Mission of the Association

To contribute to global health by uniting doctors from all over the world who are introducing innovative medical technologies, including the HSS ”Metatron” technology.

Goal of the Association

Creating a community of doctors working in the field of innovative quantum technologies to exchange experience, conduct joint research, promote new ideas, techniques and medical equipment in all countries of the world.

Objectives of the Association

Promoting the development of clinical science and integrative medicine through the exchange of experience between users of the HSS ”Metatron”, operating in different countries.

Spreading of knowledge in the field of innovative technologies developing in different countries among members of the association by organizing meetings, conferences, round tables, streams, study groups and other events.

Promoting public recognition of HSS “Metatron” and the MITIA Association among the global medical community through participation in international forums, conferences and wide coverage in the media and the Internet.

Materials

MITIA creation background

By 2022, doctors who used HSS “Metatron” for screening prenosological diagnostics in medical institutions in fifty countries around the world had accumulated unique experience and were ready to share it with the medical community.

At this time, doctors around the world were fighting the pandemic caused by the new coronavirus infection COVID-19 using various technologies and methods. However, after two years of searching for an effective solution, no effective solution was found.

In addition, the number of people suffering from chronic diseases and diseases associated with an unhealthy lifestyle has increased significantly. One of the reasons for this is that in the world, medical treatment is traditionally prescribed according to symptoms (so-called symptomatic treatment), and the cause of the disease is not given much attention.

Doctors using the HSS “Metatron” were impressed by the capabilities of this equipment, equipped with the function of information analysis of the underlying causes of diseases. Classical medicine paid little attention to this aspect.

We believe that the time has come to combine the experience and knowledge of doctors from all over the world and, by connecting to them the capabilities of the HSS “Metatron”, prepare for new challenges that will arise and are already facing humanity in order to preserve health on the planet.

We see the first step towards solving the problem of global health in collecting and publishing thirty years of research experience and achievements in the field of clinical medicine of doctors working with the HSS “Metatron”, creating the “Metatron” Innovative Technologies International Association (MITIA).

Introduction of our directors

Chairman of the Board of the MITIA Association

Vera Nesterova

General Director of the Institute of Practical Psychophysics

General Director of IPP Japan

Board Member of the MITIA Association

Hideki Kawamoto

Chief Ambassador of the MITIA Association

Director of IPP Japan

CEO of Macros Japan

Board Member of the MITIA Association

Abdullah Al Mandhari

Center for Holistic Balance, Oman

Board Member of the MITIA Association

Mohammad Ebrahimi

Head of Medical Scientific Center for Development of Bioelectric and Biofeedback Technologies, Tehran, Iran

Board Member of the MITIA Association

Reiko Suzuki

Director of IPP Japan

Information about the Associaltion

Name
Metatron Innovative Technologies International Association
Establishment date
April 11, 2022
Address
10-16 Tomizawa-cho, Nihonbashi, Chuo-ku, Tokyo, JAPAN
Articles of Association